Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$432K Sell
3,612
-1,583
-30% -$208K 0.02% 610
2025
Q4
$707K Buy
5,195
+1,476
+40% +$212K 0.04% 424
2025
Q3
$549K Buy
3,719
+351
+10% +$48.7K 0.03% 463
2025
Q2
$436K Buy
3,368
+125
+4% +$15.1K 0.03% 423
2025
Q1
$387K Buy
3,243
+765
+31% +$94.8K 0.03% 359
2024
Q4
$287K Buy
2,478
+495
+25% +$62.6K 0.03% 409
2024
Q3
$268K Buy
1,983
+55
+3% +$7.36K 0.02% 381
2024
Q2
$261K Sell
1,928
-105
-5% -$14.3K 0.02% 380
2024
Q1
$263K Sell
2,033
-1,717
-46% -$207K 0.02% 387
2023
Q4
$429K Buy
+3,750
New +$374K 0.02% 429

Other funds holding XYL

Syon Capital's XYL Position: Q1 2026 in Review

Syon Capital reduced its Xylem (XYL) stake by 30% in Q1 2026, selling an estimated $208K and leaving 3,612 shares worth $432K. The position accounts for 0.02% of the portfolio, ranked #610.

Syon Capital first reported a position in XYL in Q4 2023 and has held it in 10 quarters since. The position peaked at $707K in Q4 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Syon Capital held 3,612 shares of Xylem worth $432K as of Q1 2026.
  • Syon Capital sold 1,583 Xylem shares in Q1 2026, an estimated $208K.
  • Xylem made up 0.02% of Syon Capital's portfolio in Q1 2026, its #610 holding.
  • Syon Capital first reported a position in Xylem in Q4 2023 and has held it in 10 quarters since.
  • Syon Capital's Xylem position peaked at $707K in Q4 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.